SCHEMBL5319635

SCHEMBL5319635

CSc1nc2ccc(Nc3ncc(-c4ccc(Cl)cc4)o3)cc2s1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCP P55072 2/20 0.52
SIRT7 Q9NRC8 1/20 0.51
LMNA P02545 3/20 0.49
NPSR1 Q6W5P4 2/20 0.49
ALOX15 P16050 1/20 0.49
MAPK1 P28482 1/20 0.49
CREBBP Q92793 1/20 0.49
HSD17B10 Q99714 1/20 0.49
NPC1 O15118 6/20 0.44
ALDH1A1 P00352 5/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
MAPT P10636 5/20 0.44
RAB9A P51151 5/20 0.44
KDM4E B2RXH2 3/20 0.44
HPGD P15428 2/20 0.44
HTT P42858 2/20 0.44
PKM P14618 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5316833 0.89 IMPDH2 (0.54) VCPLMNANPSR1ALOX15MAPK1
SCHEMBL5316977 0.84 VCP (0.55) VCPSIRT7IMPDH2PIK3CGALOX5
SCHEMBL5318214 0.80 PIK3CG (0.62) VCPSIRT7HSD17B10NPC1ALDH1A1
SCHEMBL5316983 0.78 VCP (0.58) VCPSIRT7NPC1MEN1KMT2A
SCHEMBL5318254 0.73 VCP (0.58) VCPSIRT7IMPDH2PIK3CGFLT1
SCHEMBL5316742 0.73 SIRT7 (0.60) VCPSIRT7NPC1RAB9AHTT
SCHEMBL5318096 0.73 VCP (0.55) VCPSIRT7KDM4EIMPDH2PIK3CG
SCHEMBL5319609 0.73 VCP (0.55) VCPSIRT7IMPDH2PIK3CGFLT1
SCHEMBL5320437 0.73 IMPDH2 (0.57) VCPIMPDH2FLT1FLT4KDR
SCHEMBL5316767 0.72 VCP (0.60) VCPSIRT7IMPDH2ALOX5FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007076161-A2 COMPOUNDS WITH THERAPEUTIC ACTIVITY MYRIAD GENETICS, INC (US) 2007-07-05 WO claimed
WO-2007076161-A2 COMPOUNDS WITH THERAPEUTIC ACTIVITY MYRIAD GENETICS, INC (US) 2007-07-05 WO disclosed
WO-2007076161-A2 COMPOUNDS WITH THERAPEUTIC ACTIVITY MYRIAD GENETICS, INC (US) 2007-07-05 WO disclosed